Turtle Creek Wealth Advisors’s Amgen AMGN Stock Holding History

Turtle Creek Wealth Advisors's AMGN Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its Amgen (AMGN) stake by 7.3% in Q2 2026, buying an estimated $225K and bringing the position to 9,709 shares worth $3.52M. The position accounts for 0.19% of the portfolio, ranked #89.

Turtle Creek Wealth Advisors first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

• Turtle Creek Wealth Advisors held 9,709 shares of Amgen worth $3.52M as of Q2 2026.
• Turtle Creek Wealth Advisors bought 658 Amgen shares in Q2 2026, an estimated $225K.
• Amgen made up 0.19% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #89 holding.
• Turtle Creek Wealth Advisors first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
• 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.